The InvesTaiwan Service Center yesterday approved an application by Sigurd Microelectronics Corp (矽格) to invest NT$4 billion (US$144.5 million) to expand smart production lines at its plants in Hsinchu County’s Jhudong (竹東) and Hukou (湖口) townships, the Ministry of Economic Affairs said.
The investment by Sigurd, which provides semiconductor back-end manufacturing services, comes as more semiconductor companies are expanding production capacity to meet increasing demand.
Photo: Grace Hung, Taipei Times
“The COVID-19-pandemic-induced stay-at-home economy and the development of new technology applications are a key driving force behind the business growth of global chip packaging and testing service providers,” the ministry said in a statement.
Sigurd is to install more smart production lines to test chips or modules used in 5G applications, artificial intelligence devices, network products and automotive electronics, the ministry said.
The company’s subsidiary, Sigurd UTC Corp (矽格聯測), in October gained the center’s permission to invest NT$2.9 billion to add clean rooms and expand smart production lines at its plants in the Hsinchu Science Park (新竹科學園區).
Thanks to sales contributions from its subsidiary, Sigurd Microelectronics reported consolidated revenue of NT$15.16 billion for the first 11 months of this year, up 35.16 percent from a year earlier.
Sigurd was one of eight local companies that yesterday obtained the center’s permission to join the government’s three major programs under the Invest in Taiwan initiative, the ministry said.
The companies, which include Wus Printed Circuit Co (楠梓電子), Forming Bicycles Parts Co (鋒明興業) and SCI Pharmtech Inc (旭富製藥), are to invest a combined NT$9.7 billion, the ministry said.
As of yesterday, the center had approved 1,134 applications from Taiwanese businesses to invest a total of NT$1.62 trillion through the three incentive programs launched in early 2019, the ministry said.
The investments pledged so far are expected to generate 128,635 jobs, it said.
Another 51 firms are awaiting approval to invest, it added.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining